AI-based drug developer Basecamp valued at $800 million after $140 million funding round

Economic Times Techen

AI-based drug developer Basecamp valued at $800 million after $140 million funding round

The oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO Innovation Fund, the Rockefeller Foundation and Singular, among other investors.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Economic Times Tech — open it there to read it in full.

Read the full story at Economic Times Tech
  • Anthropic
  • Företag

Related AI news